0

541299

DLCL

img img img img
No Data Available

DR LALCHANDANI LABS LIMITED Share Price Update

As of the latest trading session, DR LALCHANDANI LABS LIMITED is trading at ₹9.61, up by ₹0.00 or 0.00% from its previous close. The stock has moved between ₹9.25 and ₹9.61 today. Over the past year, the stock has delivered a return of 1.58%. In the last month, it has returned -35.11%.

Investment Returns

Over 1 Month -35.11% Over 3 Months -37.79% Over 6 Months -42.00% Over 1 Year 1.58%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

DR LALCHANDANI LABS LIMITED fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 8.30
  • P/E Ratio (TTM) 20.02
  • Beta -0.27
  • Book Value / share 16.49
  • Return on equity 3.08%
  • EPS (TTM) 0.34
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.00
info icon alternate text

DR LALCHANDANI LABS LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2025 (Values in Cr)
Revenue 4.45
Operating Expense 4.06
Net Profit 0.42
Net Profit Margin (%) 9.43
Earnings Per Share (EPS) 0.96
EBITDA 1.05
Effective Tax Rate (%) -5.00
Particulars MAR 2024 (Values in Cr)
Revenue 4.81
Operating Expense 4.42
Net Profit 0.62
Net Profit Margin (%) 12.88
Earnings Per Share (EPS) 1.43
EBITDA 1.62
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 5.04
Operating Expense 6.61
Net Profit -1.56
Net Profit Margin (%) -30.95
Earnings Per Share (EPS) -3.61
EBITDA 0.08
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 11.28
Operating Expense 10.03
Net Profit 0.93
Net Profit Margin (%) 8.24
Earnings Per Share (EPS) 2.15
EBITDA 2.40
Effective Tax Rate (%) 24.80
Particulars MAR 2021 (Values in Cr)
Revenue 9.78
Operating Expense 8.40
Net Profit 1.01
Net Profit Margin (%) 10.32
Earnings Per Share (EPS) 2.33
EBITDA 2.25
Effective Tax Rate (%) 26.81
Particulars MAR 2025 (Values in Cr)
Book Value / Share 22.98
ROE % 3.08
ROCE % 2.74
Total Debt to Total Equity 0.39
EBITDA Margin 21.12
Particulars MAR 2024 (Values in Cr)
Book Value / Share 22.02
ROE % -8.23
ROCE % -2.68
Total Debt to Total Equity 0.54
EBITDA Margin 4.99
Particulars MAR 2023 (Values in Cr)
Book Value / Share 20.59
ROE % -16.09
ROCE % -3.69
Total Debt to Total Equity 0.60
EBITDA Margin 1.79
Particulars MAR 2022 (Values in Cr)
Book Value / Share 24.16
ROE % 9.30
ROCE % 12.89
Total Debt to Total Equity 0.46
EBITDA Margin 21.90
Particulars MAR 2021 (Values in Cr)
Book Value / Share 22.01
ROE % 11.19
ROCE % 14.51
Total Debt to Total Equity 0.32
EBITDA Margin 22.90
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 3.29
Total Assets 15.74
Total Liabilities 15.74
Total Equity 9.95
Share Outstanding 0
Price to Book Ratio 0.44
Return on Assets (%) 2.64
Return on Capital (%) 2.97
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.29
Total Assets 14.99
Total Liabilities 14.99
Total Equity 9.53
Share Outstanding 0
Price to Book Ratio 0.71
Return on Assets (%) 4.11
Return on Capital (%) 4.77
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.10
Total Assets 17.71
Total Liabilities 17.71
Total Equity 8.92
Share Outstanding 0
Price to Book Ratio 1.38
Return on Assets (%) -8.82
Return on Capital (%) -11.49
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 3.53
Total Assets 18.12
Total Liabilities 18.12
Total Equity 10.48
Share Outstanding 0
Price to Book Ratio 1.37
Return on Assets (%) 5.14
Return on Capital (%) 6.42
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.89
Total Assets 15.19
Total Liabilities 15.19
Total Equity 9.55
Share Outstanding 0
Price to Book Ratio 0.63
Return on Assets (%) 6.65
Return on Capital (%) 7.81
Particulars MAR 2025 (Values in Cr)
Net Income 0.40
Cash from Operations 0.36
Cash from Investing 0.05
Cash from Financing 0.57
Net change in Cash 1.00
Free Cash Flow 0.52
Particulars MAR 2024 (Values in Cr)
Net Income 0.61
Cash from Operations -0.21
Cash from Investing 0.99
Cash from Financing -1.58
Net change in Cash -0.81
Free Cash Flow -0.10
Particulars MAR 2023 (Values in Cr)
Net Income -1.56
Cash from Operations 0.00
Cash from Investing -0.19
Cash from Financing -0.23
Net change in Cash -0.43
Free Cash Flow 0.30
Particulars MAR 2022 (Values in Cr)
Net Income 1.28
Cash from Operations 2.33
Cash from Investing -1.52
Cash from Financing 0.16
Net change in Cash 0.64
Free Cash Flow 3.42
Particulars MAR 2021 (Values in Cr)
Net Income 1.37
Cash from Operations 1.50
Cash from Investing -2.25
Cash from Financing 1.71
Net change in Cash 0.63
Free Cash Flow 3.78
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 7725.65 61.15 12.22 111082.99 6680.00 8099.00
FORTIS MALAR HOSPITALS LIMITED 58.01 23.97 3.16 108.72 40.75 82.90
SHREE PACETRONIX LTD. 141.90 21.40 3.13 53.21 66.10 283.15
TRANSGENE BIOTEK LTD. 2.85 0.00 2.34 21.59 1.83 5.26
VIMTA LABS LIMITED 478.55 35.16 6.23 2137.65 377.30 902.85
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 7725.65 76.48 11.92 111082.99 6680.00 8099.00
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 38.80 0.00 -11.27 28.98 30.02 57.48
KOVAI MEDICAL CENTER & HO 5640.40 26.17 5.18 6170.60 5010.00 6725.00

DR LALCHANDANI LABS LIMITED shareholding pattern

Holding
67.09%
32.9%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

DR LALCHANDANI LABS LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
9.61 -0.92 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 9.80
  • 26 Days 12.50
  • 10 Days 10.60
  • 50 Days 13.50
  • 12 Days 10.90
  • 100 Days 13.80
  • 20 Days 11.90
  • 200 Days 14.20
9.49 PIVOT
First Support 9.37 First Resistance 9.73 Second Support 9.13 Second Resistance 9.85 Third Support 9.01 Third Resistance 10.09
RSI 29.43 ADX 47.29 MACD -1.61 Williams % R -92.85 Commodity Channel Index (CCI) -81.91
Date 2026-04-23 Week 22667.00 Same Day 8000.00 Month 29231.00
1 Year -0.27 3 Year 0.07
Over 1 Month
-35.11% down
Over 1 Year
1.58% down
Over 3 Months
-37.79% down
Over 3 Years
-21.62% down
Over 6 Months
-42.00% down
Over 5 Years
-14.10% down

DR LALCHANDANI LABS LIMITED Corporate Actions

Top Gainers

Top Losers

DR LALCHANDANI LABS LIMITED Share Price

Dr Lalchandani Labs Limited was originally incorporated as Partnership Firm at New Delhi dated 15 September, 2011 in the name of Dr. A Lalchandani Pathology Laboratories. Thereafter, the Partnership Firm was taken over by M/s Dr Lalchandani Labs Limited on 2nd August, 2017 issued by the Registrar of Companies, Delhi vide agreement dated 31st August, 2017. The Firm was established by Dr. Arjan Lal Chandani and his son Mr. Mohit Lal Chandani as a Partnership Firm in the name of 'Dr. A Lalchandani Pathology Laboratories' in 2011 and in year 2017, they formed a Company in the name and style M/s Dr Lalchandani Labs Limited and took over the Partnership firm.

The Company is a provider of diagnostic and related healthcare tests and services in Delhi/NCR. Through its integrated network, it offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Dr Lalchandani lab is situated at Greater Kailash, New Delhi State of the art NABL accredited lab in existence since 1986 with fully automatic machines offering world-class diagnostic lab services in New Delhi.

The Company is formed to set up, engage, collaborate, acquire, purchase, maintain, open collection centres, conduct, manage, administer, own, run laboratories for carrying out pathological investigations of various branches of Bio-Chemistry, Hematology, Histopathology, Microbiology, Electrophoresis, Virology, Cytology, other pathological Investigations and Immunoassay, Immuno-Histochemistry, Molecular Pathology, Dna & Genetic Testing etc. Diagnostic healthcare testing is an essential element in the delivery of healthcare services, as it provides healthcare service providers with useful information for the diagnosis and treatment of diseases.

All routine and specialized Biochemistry, Hormone assays, Drug assays, cancer markers, Torch Tests, Elisa T.B., Ultra Sound Test, Colour Dopler Test, Pap Smear and Histopathology studies are performed offering Affordable Health Packages in New Delhi like - Platinum Health Package, Gold Health Checkup, Complete Body Profile, Basic Blood Profile Tests. Dr Lalchandani Labs also offers Best Corporate Health Checkups, Blood Bank Services across Delhi NCR. The Company is empaneled for all major panels such as CGHS (South, North and East Block), DJB, MCD, DDA etc. and offer all the services at home with Home Collection & Checkups. The Company has the ability to process 1000 samples/hour with same-day reporting. It has 5 Self-sufficient Labs and 15 collection centers across Delhi/NCR.

The Greater Kailash-Part 1 Lab is having technology in Diagnostics and boasts of being aesthetically one of the most beautiful diagnostic centers in India offering one-stop complete services such as pathology, X-ray, TMT, Ultrasound, 2D-echo, Doctor Consultations, Medical Fitness Examinations etc. The Company Incubates many Fully Automatic Machines from Only reputed Global suppliers like Siemens, Ortho
(J&J), Trans Asia, GE etc.

Apart from this, the Company is managing/servicing labs at some of the leading hospitals and operating retail outlets such as Primus Super specialty Hospital, Chanakyapuri; Nanda Hospital, Chattarpur (70 Bedded), Eden Hospital, East of Kailash (25 Bedded); Arya Samaj Mandir Sarojini Nagar- Charitable Retail Outlet, and many more. It focuses on providing patients quality diagnostic and related healthcare tests and services.

The Company raised money from public through IPO by issue and allotment of 14,00,000 Equity Shares by raising equity capital aggregating Rs 4.2 Crore in April, 2018.

Parent organization Indian Private
NSE symbol [-]
Founded 2017
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Dr Lalchandani Labs Ltd?

Answer Field

Dr Lalchandani Labs Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 9.61 as on Apr 23 2026 12:00 AM.

What is the Market Cap of Dr Lalchandani Labs Ltd Share?

Answer Field

The market cap of Dr Lalchandani Labs Ltd for NSE ₹ 0.00 & for BSE ₹ 8.30 as on Apr 23 2026 12:00 AM.

What is the 52 Week High and Low of Dr Lalchandani Labs Ltd?

Answer Field

The 52 Week High and Low of Dr Lalchandani Labs Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 21.22 and ₹ 8.15.

What is 1 year return for Dr Lalchandani Labs Ltd?

Answer Field

The 1 year returns on the stock has been 1.58%.

What is the P/E Ratio of Dr Lalchandani Labs Ltd Share?

Answer Field

As on Apr 23 2026 12:00 AM the price-to-earnings (PE) ratio for Dr Lalchandani Labs Ltd share is 20.02.

What is the PB ratio of Dr Lalchandani Labs Ltd Share?

Answer Field

As on Apr 23 2026 12:00 AM, the price-to-book (PB) ratio for Dr Lalchandani Labs Ltd share is 16.49.

How to Buy Dr Lalchandani Labs Ltd Share?

Answer Field

You can trade in Dr Lalchandani Labs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Dr Lalchandani Labs Ltd Share on Bajaj Broking App?

Answer Field

To buy Dr Lalchandani Labs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Dr Lalchandani Labs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|